Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ZILLOW GROUP, INC.Z AND ZG · Entity 3657 | Director | March 01, 2017 | March 02, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ZILLOW GROUP, INC.
Report date March 01, 2017 · Filed March 02, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $35.39 · Expires 2027-03-01 | Direct | 9,803 |
Reported balance
After 2017-03-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-03-01 · Grant · Acquired 9,803 · Balance 9,803 F1: Option is fully vested and exercisable on date of grant. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $35.39 · Expires 2027-03-01 | Direct | 13,071 |
Reported balance
After 2017-03-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-03-01 · Grant · Acquired 13,071 · Balance 13,071 F2: 1/4th of the shares subject to the option will vest and become exercisable after each-three-month period following the grant date such that the option will be fully vested and exercisable on the one-year anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Option is fully vested and exercisable on date of grant.
F2: 1/4th of the shares subject to the option will vest and become exercisable after each-three-month period following the grant date such that the option will be fully vested and exercisable on the one-year anniversary of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2017 Filed Mar 2, 2017 23:28 UTC | ZILLOW GROUP, INC. Z AND ZG · Entity 3657 | GrantStock Option (Right to Buy) · Derivative | 13,071 | $0.00 Strike: $35.39 | $0.00 |
DisclosureSEC source: 0001225208-17-005408 · doc4.xml · derivative · entry 2 Flint Peter · CIK 0001558271 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,071 Underlying: Class C Capital Stock · 13,071 shares Expires 2027-03-01 F2 · derivative.exercise_date: 1/4th of the shares subject to the option will vest and become exercisable after each-three-month period following the grant date such that the option will be fully vested and exercisable on the one-year anniversary of the grant date. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 23:28 UTC | ZILLOW GROUP, INC. Z AND ZG · Entity 3657 | GrantStock Option (Right to Buy) · Derivative | 9,803 | $0.00 Strike: $35.39 | $0.00 |
DisclosureSEC source: 0001225208-17-005408 · doc4.xml · derivative · entry 1 Flint Peter · CIK 0001558271 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,803 Underlying: Class C Capital Stock · 9,803 shares Expires 2027-03-01 F1 · derivative.exercise_date: Option is fully vested and exercisable on date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.